Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvette Meissner

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Arthritis Research & Therapy|November 16, 2019
European Network of Pregnancy Registers in Rheumatology (EuNeP)-an overview of procedures and data collectionYvette Meissner, Anja Strangfeld, Nathalie Costedoat-Chalumeau, et al.
Arthritis Research & Therapy|August 7, 2016
Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritisYvette Meissner, Angela Zink, Jörn Kekow, et al.
RMD Open|May 6, 2022
Effectiveness of remote care interventions: a systematic review informing the 2022 EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseasesAndréa Marques, Philipp Bosch, Annette de Thurah, et al.
Annals of the Rheumatic Diseases|April 16, 2025
Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendationsAndrea Pluma, Sabrina Hamroun, Linda Rüegg, et al.
Annals of the Rheumatic Diseases|June 26, 2025
Comparative risk of incident malignancies in rheumatoid arthritis patients treated with Janus kinase inhibitors or bDMARDs: observational data from the German RABBIT registerMartin Schaefer, Alina Purschke, Vera Zietemann, et al.
Seminars in Arthritis and Rheumatism|July 27, 2023
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Maarten Boers, et al.
Annals of the Rheumatic Diseases|November 6, 2023
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studiesTeresa A Simon, Lixian Dong, Samy Suissa, et al.
Seminars in Arthritis and Rheumatism|December 3, 2023
Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Mary Lou Skovron, et al.
Pharmacoepidemiology and Drug Safety|August 14, 2024
Rhekiss-The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic DiseasesAnja Strangfeld, Yvette Meissner, Anja Weiß, et al.
Annals of the Rheumatic Diseases|August 12, 2022
Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP)Yvette Meissner, Anja Strangfeld, Anna Molto, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Arthritis Research & Therapy|November 16, 2019
European Network of Pregnancy Registers in Rheumatology (EuNeP)-an overview of procedures and data collectionYvette Meissner, Anja Strangfeld, Nathalie Costedoat-Chalumeau, et al.
Arthritis Research & Therapy|August 7, 2016
Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritisYvette Meissner, Angela Zink, Jörn Kekow, et al.
RMD Open|May 6, 2022
Effectiveness of remote care interventions: a systematic review informing the 2022 EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseasesAndréa Marques, Philipp Bosch, Annette de Thurah, et al.
Annals of the Rheumatic Diseases|April 16, 2025
Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendationsAndrea Pluma, Sabrina Hamroun, Linda Rüegg, et al.
Annals of the Rheumatic Diseases|June 26, 2025
Comparative risk of incident malignancies in rheumatoid arthritis patients treated with Janus kinase inhibitors or bDMARDs: observational data from the German RABBIT registerMartin Schaefer, Alina Purschke, Vera Zietemann, et al.
Seminars in Arthritis and Rheumatism|July 27, 2023
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Maarten Boers, et al.
Annals of the Rheumatic Diseases|November 6, 2023
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studiesTeresa A Simon, Lixian Dong, Samy Suissa, et al.
Seminars in Arthritis and Rheumatism|December 3, 2023
Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Mary Lou Skovron, et al.
Pharmacoepidemiology and Drug Safety|August 14, 2024
Rhekiss-The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic DiseasesAnja Strangfeld, Yvette Meissner, Anja Weiß, et al.
Annals of the Rheumatic Diseases|August 12, 2022
Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP)Yvette Meissner, Anja Strangfeld, Anna Molto, et al.
Pageof 3